C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways. (2023). Journal of Applied Oral Science, 31, e20220404. https://doi.org/10.1590/1678-7757-2022-0404